Sera Prognostics Announces Pricing For PreTRM® Test, The Only Broadly Validated Blood Test To Assess Risk Of Preterm Birth
/PRNewswire/ -- Sera Prognostics Inc., The Pregnancy Company® (NASDAQ: SERA), focused on improving maternal and neonatal health by providing innovative...
United States Salt Lake City Gregoryc Critchfield Peter Denardo Erich Sandoval Centers For Medicare Medicaid Services
Source: prnewswire.com